Anxiolytic and hypnotic use by general hospital inpatients. The impact of psychopathology and general medical conditions.
This study explored the relative impact of general medical conditions and psychopathology on the current and lifetime use of anxiolytic and/or hypnotic drugs by general hospital inpatients. One hundred and five consecutive patients, admitted to an internal medicine department, were assessed by a structured interview about current and lifetime use of anxiolytic and/or hypnotic drugs, and with somatic and psychopathology scales. Eighty percent of patients reported using anxiolytics and/or hypnotics at least once in a lifetime, 62.9% in the last year, 55.2% in the last 3 months, and 42.9% in the last week. Correlations were found between drug use and current levels of anxiety and depression, but not somatic pathology. Psychological suffering appeared to be a major determinant for anxiolytic and/or hypnotic use by patients with general medical conditions. Consumption rates were higher than in the general population, but there was no direct link between somatic morbidity and drug use.
Pélissolo
A
A
Department of Psychiatry, Fernand Widal Hospital, AP-HP, Paris, France.
Notides
C
C
Lépine
J P
JP
Bisserbe
J C
JC
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy / Q000453:epidemiology; D016009:Chi-Square Distribution; D016001:Confidence Intervals; D003863:Depression / Q000188:drug therapy / Q000453:epidemiology; D017723:Drug Utilization Review / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D007297:Inpatients / Q000706:statistics & numerical data; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy / Q000453:epidemiology*; D008875:Middle Aged; D010297:Paris / Q000453:epidemiology; D012646:Self Administration / Q000706:statistics & numerical data; D012737:Sex Factors
D014151:Anti-Anxiety Agents; D006993:Hypnotics and Sedatives